Diurnal Intraocular Pressure with Bimatoprost/Timolol Fixed Combination versus Latanoprost/Timolol Fixed Combination in Healthy Subjects

키워드

참고문헌 (46)

1. Quigley HA, "The number of people with glaucoma worldwide in 2010 and 2020", Br J Ophthalmol, 90, pp.262~267 (2006)
2. Klaver CC, "Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study", Arch Ophthalmol, 116, pp.653~658 (1998)
3. Heijl A, "Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial", Arch Ophthalmol, 120, pp.1268~1279 (2002)
4. Kass MA, "The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma", Arch Ophthalmol, 120, pp.701~713 (2002)
5. Fremont AM, "Patterns of care for open-angle glaucoma in managed care", Arch Ophthalmol, 121, pp.777~783 (2003)
6. Diestelhorst M, "Comparison of two fixed combinations of latanoprost and timolol in open-angle glaucoma", Graefes Arch Clin Exp Ophthalmol, 236, pp.577~581 (1998)
7. Larsson LI, "Effect on intraocular pressure during 24 hours after repeated administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension", J Glaucoma, 10, pp.109~114 (2001)
8. Larsson LI, "The effect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension", Acta Ophthalmol Scand, 79, pp.125~128 (2001)
9. Higginbotham EJ, "Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial", Arch Ophthalmol, 120, pp.915~922 (2002)
10. Pfeiffer N, "European Latanoprost Fixed Combination Study Group. A comparison of the fixed combination of latanoprost and timolol with its individual components", Graefes Arch Clin Exp Ophthalmol, 240, pp.893~899 (2002)
11. Diestelhorst M, "European Latanoprost Fixed Combination Study Group. A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension", Br J Ophthalmol, 88, pp.199~203 (2004)
12. Shin DH, "Efficacy and safety of the fixed combinations latanoprost", timolol versus dorzolamide, Ophthalmology, pp.2004, 111[DOI]
13. Konstas AG, "24-Hour control with a latanoprost-timolol fixed combination vs timolol alone", Arch Ophthalmol, 124, pp.1553~1557 (2006)
14. Martinez A, "Bimatoprost", timolol fixed combination vs latanoprost, Eye (Lond), pp.2009, 23[DOI]
15. Lewis RA, "The safety and efficacy of bimatoprost", timolol fixed combination: a 1-year double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension, 2010, pp.19, 424~426
16. Brandt JD, "Bimatoprost", timolol fixed combination: a 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension, 2008, pp.17, 211~216
17. Konstas AG, "Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients", Ophthalmology, 112, pp.262~266 (2005)
18. Robin AL, "Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?", Ophthalmology, 112, pp.863~868 (2005)
19. Hasegawa K, "Diurnal variation of intraocular pressure in suspected normal-tension glaucoma", Jpn J Ophthalmol, 50, pp.449~454 (2006)
20. Tajunisah I, "Diurnal variation of intraocular pressure in suspected glaucoma patients and their outcome", Graefes Arch Clin Exp Ophthalmol, 245, pp.1851~1857 (2007)
21. Sit AJ, "Asymmetry of right versus left intraocular pressures over 24 hours in glaucoma patients", Ophthalmology, 113, pp.425~430 (2006)
22. Liu JH, "Variation of 24-hour intraocular pressure in healthy individuals: right eye versus left eye", Ophthalmology, 112, pp.1670~1675 (2005)
23. 이종연, "The Efficacy of a Monocular Drug Trial in Normal-Tension Glaucoma", Korean Journal of Ophthalmology, 26(1), pp.26~31 (2012), 대한안과학회
24. Realini T, "The uniocular drug trial and second-eye response to glaucoma medications", Ophthalmology, 111, pp.421~426 (2004)
25. Dayanir V, "The one-eye trial and fellow eye response to prostaglandin analogues", Clin Experiment Ophthalmol, 36, pp.136~141 (2008)
26. Chaudhary O, "Predicting response to glaucoma therapy in one eye based on response in the fellow eye: the monocular trial", Arch Ophthalmol, 126, pp.1216~1220 (2008)
27. Takahashi M, "Discrepancy of the intraocular pressure response between fellow eyes in one-eye trials versus bilateral treatment: verification with normal subjects", J Glaucoma, 17, pp.169~174 (2008)
28. Noecker RS, "A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma", Am J Ophthalmol, 135, pp.55~63 (2003)
29. Orzalesi N, "Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension", Ophthalmology, 113, pp.239~246 (2006)
30. Parrish RK, "A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study", Am J Ophthalmol, 135, pp.688~703 (2003)
31. Woodward DF, "Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024)", J Pharmacol Exp Ther, 305, pp.772~785 (2003)
32. Sharif NA, "Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells", J Ocul Pharmacol Ther, 19, pp.501~515 (2003)
33. Takagi Y, "Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug", Exp Eye Res, 78, pp.767~776 (2004)
34. Cho SW, "Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma", Jpn J Ophthalmol, 54, pp.407~413 (2010)
35. Konstas AG, "Twenty-four-hour control with latanoprost-timolol-fixed combination therapy vs latanoprost therapy", Arch Ophthalmol, 123, pp.898~902 (2005)
36. Simsek S, "Longterm effects of prostaglandin analogues on the anterior chamber depth of patients with primary open-angle glaucoma", Cutan Ocul Toxicol, 28, pp.125~128 (2009)
37. Gutierrez-Ortiz C, "Short-term effects of latanoprost on anterior chamber depth in patients with glaucoma or ocular hypertension", Invest Ophthalmol Vis Sci, 47, pp.4856~4859 (2006)
38. Martinez A, "A comparison of the safety and intraocular pressure lowering of bimatoprost", timolol fixed combination versus latanoprost, Curr Med Res Opin, pp.2007, 23[DOI]
39. Chen J, "Bimatoprost: mechanism of ocular surface hyperemia associated with topical therapy", Cardiovasc Drug Rev, 23, pp.231~246 (2005)
40. Russo A, "Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review", Clin Ophthalmol, 2, pp.897~905 (2008)
41. Feldman RM, "Conjunctival hyperemia and the use of topical prostaglandins in glaucoma and ocular hypertension", J Ocul Pharmacol Ther, 19, pp.23~35 (2003)
42. Bhorade AM, "The monocular trial controversy: a critical review", Curr Opin Ophthalmol, 20, pp.104~109 (2009)
43. Drance SM, "The uniocular therapeutic trial in the management of elevated intraocular pressure", Surv Ophthalmol, 25, pp.203~205 (1980)
44. Piltz J, "Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study", Am J Ophthalmol, 130, pp.441~453 (2000)
45. Liu JH, "Twenty-fourhour intraocular pressure pattern associated with early glaucomatous changes", Invest Ophthalmol Vis Sci, 44, pp.1586~1590 (2003)
46. Wax MB, "Emerging perspectives in glaucoma: optimizing 24-hour control of intraocular pressure", Am J Ophthalmol, 133(Suppl), pp.S1~S10 (2002)

관련 논문AI추천